List of Figures 1.1. 3D bioprinting forecast scenarios to 2024 1.2. The widening gap in transplant demand and supply 1.3. A roadmap for 3D bioprinting 2.1. 2D (left) vs. 3D (right) cultured cells 2.2. Scaffold built human bladders 2.3. Schematic of the 3D bioprinting process 2.4. Timeline for medical applications of 3D bioprinting 2.5. Organovo 3D bioprinter 3.1. 3D inkjet bioprinting 3.2. SWOT analysis for inkjet printing 3.3. Extrusion based bioprinting 3.4. SWOT analysis for extrusion/syringe based bioprinting 3.5. Magnetic levitation bioprinting 3.6. Magnetic levitation 3.7. SWOT analysis for magnetic levitation based bioprinting 3.8. Laser guided (left) and laser induced (right) bioprinting 3.9. SWOT analysis for laser-assisted bioprinting 3.10. SWOT analysis for valve-based bioprinting 4.1. Pipeline for drug discovery View Full Report With Complete TOC at http://www.researchmoz.us/3d-bioprinting-2014-2024-applications-markets-and-players-report.html

1. 3D Bioprinting 2014-2024: Applications, Markets and Players
3D bioprinting constitutes a raft of technologies, commercial and not-yet commercial, which have the potential to significantly impact a number of major
markets, including in vitro testing for more efficient drug discovery and toxicity testing of personal consumer products, as well as the clinical fields relating to
implant/grafting of human tissue. Though not yet employed within its addressable markets (current bioprinter sales and products are to research and
development organisations only), the potential for rapid deployment in some areas already exists, subject to adequate funding being made available.
Drug discovery
Drug discovery is a highly expensive process which in most cases will end in failure to gain regulatory clearance (see figure 1). The reason for this high failure
rate is related to the lack of sufficiently accurate pre-clinical (prior to human volunteer) testing methodologies which have to date been limited to 2-dimensional
human cell assays together with animal testing.
table Of Contents
1. Executive Summary
2. Introduction
3. Technologies
3.1. Inkjet Based Bioprinting
3.2. Syringe/extrusion Based Bioprinting
3.3. Magnetic Levitation Bioprinting
3.4. Laser Assisted Bioprinting
3.5. Valve-based Bioprinting
3.6. Technology Summary
4. Applications
4.1. Medical
4.1.1. Drug Screening
4.1.2. Regenerative Medicine
4.1.3. Tissue Replacement (avascular)
4.1.4. Tissue Replacement (vascular)
4.2. Dental
4.3. Consumer/personal Product Testing
4.4. Biosensors
4.5. Food And Animal Product Bioprinting
4.6. Bioinks
4.6.1. Cells
4.6.2. Growth Factors/proteins
4.6.3. Support Material
5. Markets
5.1. Market Structure And Key Players
5.2. Value Chain
5.3. Market Barriers
5.4. Benefits
6. Roadmap And Forecasts
7. Company Interviews
7.1. Digilab Inc.
7.2. Microfab Technologies Inc.
7.3. N3d Biosciences Inc.
7.4. Nscrypt Inc.
7.5. Organovo
7.6. Regenhu Ltd
7.7. Tivido Biodevices
ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your
research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and
3D Bioprinting 2014-2024: Applications, Markets and Players

2. across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an
informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
Contact:
M/s Sheela,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-997-4948
Email: sales@researchmoz.us
Website: http://www.researchmoz.us/
3D Bioprinting 2014-2024: Applications, Markets and Players